title: Lamivudine in the treatment of hepatitis B virus-related polyarteritis nodosa.
authors.affiliation: Department of Internal Medicine, Joan XXIII University Hospital, C/Dr. Mallafré Guasch 4, 43007 Tarragona, Spain. tauguet.hj23.ics@gencat.net
authors.forename: Teresa
authors.initials: T
authors.lastname: Auguet
authors.forename: Patricia
authors.initials: P
authors.lastname: Barragan
authors.forename: Rafael
authors.initials: R
authors.lastname: Ramírez
authors.forename: Joan Carles
authors.initials: JC
authors.lastname: Quer
authors.forename: Joan Josep
authors.initials: JJ
authors.lastname: Sirvent
authors.forename: Cristóbal
authors.initials: C
authors.lastname: Richart
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010488:Polyarteritis Nodosa / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D019380:Anti-HIV Agents; D006513:Hepatitis B e Antigens; D007166:Immunosuppressive Agents; D019259:Lamivudine; D003520:Cyclophosphamide; D008775:Methylprednisolone